 Piglycoprotein, PGP, is a membrane transporter that limits cellular uptake and distribution of xenobiotics and toxic substances, impedes drug absorption, permeability, and retention, and is overexpressed in cancer cells, leading to resistance to chemotherapeutic agents. Strategies are being developed to overcome PGP-needed drug transport for successful drug delivery and targeting.